Newman Dignan & Sheerar, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 914 filers reported holding NOVARTIS A G in Q4 2014. The put-call ratio across all filers is 0.42 and the average weighting 0.6%.

Quarter-by-quarter ownership
Newman Dignan & Sheerar, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$376,780
+0.9%
3,6990.0%0.12%
+7.8%
Q2 2023$373,266
+9.7%
3,6990.0%0.12%
+5.5%
Q1 2023$340,308
+1.4%
3,6990.0%0.11%
-1.8%
Q4 2022$335,573
+19.4%
3,6990.0%0.11%
+152.3%
Q3 2022$281,000
-10.2%
3,6990.0%0.04%
-58.9%
Q2 2022$313,000
-3.7%
3,6990.0%0.11%
+72.6%
Q1 2022$325,000
+0.3%
3,6990.0%0.06%
-36.7%
Q4 2021$324,000
+5.9%
3,699
-1.1%
0.10%
+11.4%
Q3 2021$306,000
-10.3%
3,7390.0%0.09%
-23.5%
Q2 2021$341,000
+6.6%
3,7390.0%0.12%
-0.9%
Q1 2021$320,000
-99.9%
3,7390.0%0.12%
-99.8%
Q4 2020$353,074,000
+100778.3%
3,739
-7.2%
56.77%
+38784.2%
Q3 2020$350,000
+3.2%
4,0270.0%0.15%0.0%
Q2 2020$339,000
-1.7%
4,0270.0%0.15%
-19.3%
Q1 2020$345,000
-13.5%
4,027
-4.5%
0.18%
+320.9%
Q4 2019$399,000
-88.6%
4,216
+4.7%
0.04%
-97.4%
Q3 2019$3,500,000
+851.1%
4,0270.0%1.65%
+16390.0%
Q2 2019$368,000
-4.9%
4,0270.0%0.01%
-93.6%
Q1 2019$387,000
+11.8%
4,0270.0%0.16%
+437.9%
Q4 2018$346,000
-90.0%
4,0270.0%0.03%
-98.1%
Q3 2018$3,447,000
+1033.9%
4,0270.0%1.51%
+7445.0%
Q2 2018$304,000
-6.7%
4,0270.0%0.02%
-87.9%
Q1 2018$326,000
-3.6%
4,0270.0%0.16%
-2.4%
Q4 2017$338,000
-2.3%
4,0270.0%0.17%
-8.2%
Q3 2017$346,000
+3.0%
4,0270.0%0.18%
-1.1%
Q2 2017$336,000
+13.5%
4,027
+1.0%
0.19%
+42.0%
Q1 2017$296,000
+2.1%
3,9870.0%0.13%
-26.0%
Q4 2016$290,000
-7.9%
3,9870.0%0.18%
-10.6%
Q3 2016$315,000
-4.3%
3,9870.0%0.20%
-3.9%
Q2 2016$329,000
+13.8%
3,9870.0%0.21%
-1.9%
Q1 2016$289,000
-13.7%
3,987
+2.3%
0.21%
-11.4%
Q4 2015$335,000
-6.4%
3,8990.0%0.24%
+3.0%
Q3 2015$358,000
-6.5%
3,8990.0%0.23%
-16.7%
Q2 2015$383,000
+0.3%
3,899
+0.8%
0.28%
+1.1%
Q1 2015$382,000
+6.7%
3,8690.0%0.27%
+27.6%
Q4 2014$358,000
-1.6%
3,8690.0%0.21%
-21.6%
Q3 2014$364,000
-89.6%
3,8690.0%0.27%
-86.3%
Q2 2014$3,505,000
+547.9%
3,869
-39.3%
2.00%
+418.4%
Q1 2014$541,000
+5.7%
6,3690.0%0.38%
+1440.0%
Q4 2013$512,000
+4.7%
6,3690.0%0.02%
-93.4%
Q3 2013$489,000
+8.7%
6,3690.0%0.38%
+985.7%
Q2 2013$450,0006,3690.04%
Other shareholders
NOVARTIS A G shareholders Q4 2014
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders